Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Omega 3 in the management of nephrotoxicity In an in vivo study by Shi et al
Statistical analysis All data were statistically analyzed using GraphPad Prism 8.0, SPSS, and R software and presented by Adobe Illustrator
Randomized controlled trials before the issue of CVOTs by the FDA in 2008 mainly focused on the efficacy of the blood glucose-lowering effects and a broad spectrum of adverse effects, with limited numbers of cardiovascular adverse events and relatively short follow-up duration
Methods This was a prospective analytical study of 28 critically ill patients with a septic shock who were monitored from admission (initial) to 3 days of stay (final) in the intensive care unit (ICU)
32 MaLPengSWeiJZhaoMAhmadKAChenJet al
